Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - FREE CASH FLOW
Free Cash Flow AKBA - Akebia Therapeutics, Inc.
-23.4 M
LAST VALUE
69.60%
2 YEAR CAGR
25.08%
5 YEAR CAGR
-7.49%
10 YEAR CAGR